Dec 21, 2022 | Jessie Daw
Dr. Sigrun Thorsteinsdottir, MD, PhD, gave a comprehensive review of smoldering myeloma directed toward practitioners. The session was very informative and so I’d like to dedicate this blog to sharing this information from a patient’s perspective, as I’ll highlight...
Dec 13, 2022 | Jessie Daw
As I mentioned in my previous blog, the uncertainties of living with smoldering multiple myeloma (SMM) can be whittled down to two “million dollar” questions: (a) “Will I progress to active disease?” and (b) “Should I consider treatment, and if so, how and when?” This...
Dec 11, 2022 | Jack Aiello
Today, I began at 4 a.m. PST for the privilege of being able to attend the International Myeloma Working Group (IMWG) meeting. The IMWG has more than 260 myeloma specialists who meet twice a year. Whenever you see a phrase such as “…responses per IMWG guidelines,”...
Dec 7, 2022 | Diane Hunter
When I was diagnosed with multiple myeloma in January 2017, my daughter was a sophomore in college. The last thing I wanted for her was to be worried about me. When I asked my oncologist if I should tell her in person, he told me, “Your daughter is stronger than you...
Dec 6, 2022 | Teresa Miceli
Hello Myeloma community! It is that time of year again – the 64th American Society of Hematology (ASH) annual meeting, being held in New Orleans, LA (NOLA) from December 10-13, 2022. The Support Group Leaders (SGLs) are back at it for the first Hybrid IMF SGLs@ASH....
